FGFR2 and head and neck squamous cell carcinoma: To begin to understand the effect of therapeutic inhibition of FGFR2 in HNSCC, we performed propidium iodide (PI) staining of cells treated with increasing doses of BGJ398 (Figure 6B–6D).